Pulmonary endothelial and epithelial integrity and neutrophil infiltration after endotoxin in interleukin-1 receptor knockout mice

Shock

Volumn 13, Issue 2, 2000, Pages 117-125

  Sutton, E Truitt ^a,b   Norman, James ^a   Rao, Papineni S ^a   Graham, Lloyd B ^a   Newton, Catherine A ^a   Richards, Ira S ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Electron microscopy; Interleukin 6; Knockout mice; Nitric oxide; Septic shock

Indexed keywords

ENDOTOXIN; ENDOTOXIN, ESCHERICHIA COLI; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 6; NITRIC OXIDE;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CELL ORGANELLE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; ENTEROBACTER INFECTION; LUNG; LUNG ALVEOLUS; LUNG LAVAGE; MALE; METABOLISM; MOUSE; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; RESPIRATORY SYSTEM; RESPIRATORY TRACT MUCOSA; SEPTIC SHOCK; TRACHEA; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; ENDOTHELIUM, VASCULAR; ENDOTOXINS; ESCHERICHIA COLI INFECTIONS; INTERLEUKIN-6; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NITRIC OXIDE; ORGANELLES; PULMONARY ALVEOLI; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE I; RESPIRATORY MUCOSA; RESPIRATORY SYSTEM; SHOCK, SEPTIC; TRACHEA;

EID: 0034131978     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200013020-00005     Document Type: Article

References (35)

1. Pruitt JH, Copeland EM III, Moldawer LL: Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock 3:235-251, 1995.
2. Cody CS, Dunn DL: Endotoxins in septic shock. In Neugebauer EA, Holaday JW (eds): Handbook of Mediators in Septic Shock. Boca Raton FL: CRC Press, 1993, pp 1-37.
3. Brigham KL, Meyrick B: Endotoxin and lung injury: state of the art. Am Rev Respir Dis 133:913-927, 1986.
4. Schwartz DA, Thorne PS, Jagielo PJ, White GE, Bleuer SA, Frees KL: Endotoxin responsiveness and grain dust-induced inflammation in the lower respiratory tract. Am J Physiol 267:L609-L617, 1994.
5. Repine JE: Neutrophils, oxygen radicals and the adult respiratory distress syndrome. In Said SI (ed): The Pulmonary Circulation and Acute Lung Injury. New York NY: Futura, 1985, pp 249-281.
6. Jarreau PH, D'Ortho MP, Boyer V, Harf A, Macquin-Mavier I: Effects of capsaicin on the airway responses to inhaled endotoxin in the guinea pig. Am J Respir Crit Care Med 149:128-133, 1994.
7. Folkerts G, Henricks PAJ, Slootweg PJ, Nijkamp FP: Endotoxin-induced inflammation and injury of guinea pig respiratory airways cause bronchial hyporeactivity. Am Rev Respir Dis 137:1441-1448, 1988.
8. Yamawaki I, Tamaoki J, Kanemura T, Horii S, Takizawa T: Effects of lipopolysacharide from Pseudomonas aeruginosa on airway smooth muscle functions in guinea pigs. Respiration 57:268-274, 1990.
9. Meyrick BO: Endotoxin-mediated pulmonary endothelial cell injury. Fed Proc 45:19-24, 1986.
10. Young JS, Headrick JP, Berne, RM: Endothelial-dependent and -independent responses in the thoracic aorta during endotoxin shock. Circ Shock 35:25-30, 1991.
11. Zhou Z, Price JM, Sutton ET, Baker CH: In vitro femoral arterial responses to vasoconstrictor and vasodilator agents in endotoxin shock. Life Sci 54:9-16, 1993.
12. Sutton ET, Zhou Z, Baker CH, Price JM, Chen Y: Differences in arterial and arteriolar endothelial structure during endotoxin shock. Circ Shock 41:71-76, 1993.
13. Cannon JG, Thompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JW, Endres S, Lonnemann G, Corsetti J, Chernow B, Wolmore DW, Wolff SM, Burke JF, Dinarello CA: Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 101:79-84, 1990.
14. Fischer E, Marano MA, Barber AE, Hudson A, Lee K, Rock CS, Hawes AS, Thompson RC, Hayes TJ, Anderson TD, Benjamin WR, Lowry SF, Moldawer LL: Comparison between effects of interleukin-1α administration and sublethal endotoxemia in primates. Am J Physiol 261:R442-R452, 1991.
15. Smith JW, Urba WJ, Curti BD, Elwood LJ, Steis RG, Janik JE, Sharfman WH, Miller LL, Fenton RG, Conlon KC, Rossio J, Kopp W, Shimuzut M, Oppenhiem JJ, Longo D: The toxic and hematologic effects of interleuin-1 alpha administered in a phase 1 trial to patients with advanced malignancies. J Clin Oncol 10:1141-1152, 1992.
16. Ohlsson K, Björk P, Bergenfeldt M, Hageman R, Thompson RC: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348:550-552, 1990.
17. Norman, JG, Sutton ET, Franz MS, Baker CH: Maintenance of dynamic microvascular function and structure in a rat model of endotoxic shock by blockade of the interleukin-1 receptor. Shock 3:369-375, 1995.
18. Sutton ET, Norman JG, Newton CA, Hellermann GR, Richards IS: Endothelial structural integrity is maintained during endotoxic shock in an interleukin-1 type 1 receptor knockout mouse. Shock 7:105-110, 1997.
19. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771-778, 1993.
20. G-monomethyl-L-arginine. J Cardiovac Pharmacol 20:S132-S134, 1992.
21. Norman JG, Fink GS, Franz MG, Guffey G, Carter G, Davison B, Sexton C, Glaccum M: Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg 223:163-169, 1996.
22. Yeung RS, Penninger J, Mak TW: Genetically modified animals and immuno-deficiency. Curr Opinion Immunol 5:585-594, 1993.
23. Cunha FQ, Assreuy J, Moss DW, Rees D, Leal LMC, Moncada S, Carrier M, O'Donnell CA, Liew FY: Differential induction of nitric oxide synthase in various organs of the mouse during endotoxemia: role of TNF-α and IL-1-β. Immunology 81:211-215, 1994.
24. Starnes HF Jr, Pearce MK, Tewari A, Yim JH, Zou JC, Abrams JS: Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-α challenge in mice. J Immunol 145:4185-4191, 1990.
25. 15N] nitrate in biological fluids. Anal Biochem 126:131-138, 1982.
26. Benjamin D, Wormsley S, Dower SK: Heterogeneity on interleukin (IL)-1 receptors expressed on human B cell lines. Differences in the molecular properties of IL-1α and IL-1β binding sites. J Biol Chem 265:9943-9951, 1990.
27. Miyajima A, Kitamura T, Harada N, Yokata T, Arai K: Cytokine receptors and signal transduction. Annu Rev Immunol 10:295-311, 1992.
28. Ulich TR, Songmei Y, Guo K, del Castillo J, Eisenberg SP, Thompson RC: The intracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin-and IL-1-induced acute inflammation. Am J Pathol 138:521-524, 1991.
29. Baker CH, Sutton ET, Price JM: Arteriolar reactivity of endotoxin-tolerant rats after hemorrhage and reinfusion. Shock 4:455-460, 1995.
30. Szabó C, Thiemermann C, Wu CC, Perretti M, Vane JR: Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci USA 91:271-275, 1994.
31. León P, Redmond HP, Daly JM: Interleukin 1 and its relationship to endotoxin tolerance. Arch Surg 127:145-151, 1992.
32. Dinarello CA: Cytokines as mediators in the pathogenesis of septic shock. Curr Top Microbiol Immunol 216:133-165, 1996.
33. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1991.
34. Geller DA, de Vera ME, Russell DA, Shapiro RA, Nussler AK, Simmons RL, Billiar TR: A central role for IL-1β in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1β induces hepatic nitric oxide synthesis. J Immunol 155:4890-4898, 1995.
35. Szabó C, Wu CC, Gross SS, Thiemermann C, Vane JR: Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. Eur J Pharmacol 250:151-160, 1993.